Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer

Back

Krzysztof Cudzik

Ostrowieckie Medical Center Of Civil Company, Poland

Title: Every Breath Counts: Halt the rise of COPD, Prevention of COPD in Poland

Biography

Biography: Krzysztof Cudzik

Abstract

Chronic Obstructive Pulmonary Disease (COPD) is one of the most common chronic illnesses and very important social problem. It is the third leading cause of death among chronic diseases worldwide causing 3,1mln deaths a year globally. About 250mln patients suff er from COPD all over the world. In Poland statistics stay that about 2mln people are diagnosed with COPD and it is 10% of screened population aft er 40 years old. On the other hand, it is estimated that the disease is diagnosed at an early stage in less than 20% of patients, and this is the reason why a signifi cant population of patients is not diagnosed or diagnosed only in the advanced stage of the disease. Regarding prevalence, direct costs of treatment COPD in
Poland are very high and estimated about 441,8mln PLN per year and include pharmacotherapy (297,1 mln PLN), general care and specialist appointments (31,6 mln PLN), hospitalization (96,1 mln PLN), rehabilitation (6,3 mln PLN), home oxygen therapy (6,3 mln PLN), nursing care (4,4 mln PLN). An important element in prevention is early smoking cessation, reduction of exposure to harmful factors and infl uenza vaccination. Limiting these factors is benefi cial to the patient's health and reduces the risk of exacerbations. Patients should pay attention to normal body weight and a healthy diet. Early diagnosis of COPD is also very important. Emotional support and a psychological support are particularly important in patients with advanced COPD. Depression signifi cantly increases the risk of exacerbations and aff ects the quality of life of patients. Systematic use of drugs and respiratory rehabilitation increases respiratory effi ciency. Prevention of this disease is most important to reduce still growing prevalence and costs.